CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Instem PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Instem PLC
Diamond Way, Stone Business Park
Phone: +44 1785825600p:+44 1785825600 STONE, ST15 0SD  United Kingdom Fax: +44 1785825633f:+44 1785825633
This company was Merged or Acquired on 11/27/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Instem plc is a United Kingdom-based company that is a provider of information technology (IT) solutions to the global life sciences market. The Company operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration. Study Management Solutions offers software that enables organizations to collect, review, manage and report discovery and preclinical data. Regulatory Solutions provides software, outsourced services and consulting for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The Company's In Silico Solutions enable researchers to generate scientific insights through the identification, extraction and analysis of information. Clinical Trials Acceleration Solutions offers technology solutions and consulting services to facilitate data integration, statistics, analytics and insights for companies of any size or stage of clinical trial analysis.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes---Yes

Industries
SIC Code Description
7372 Prepackaged software
7371 Computer programming services
5045 Computers and computer peripheral equipment and software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board DavidGare 9/15/2010 9/15/2010
Chief Executive Officer, Executive Director Philip J.Reason 9/15/2010
Chief Financial Officer, Company Secretary, Executive Director Nigel J.Goldsmith 11/30/2011 11/30/2011
3 additional Officers and Directors records available in full report.

Business Names
Business Name
BioWisdom Limited
d-wise, Inc.
Instem Clinical Holdings Limited
16 additional Business Names available in full report.

General Information
Number of Employees: 493 (As of 12/31/2022)
Outstanding Shares: 24,053,390 (As of 11/17/2023)
Stock Exchange: LON
Fax Number: +44 1785825633


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024